XORTX Therapeutics (XRTX) Exchange Rate Effect (2021 - 2026)
XORTX Therapeutics (XRTX) posted Exchange Rate Effect of -$763.0 for Q1 2026, down 118.25% on a QoQ basis from $4181.0 in Q4 2025, and down 167.7% year-over-year from $1127.0 in Q1 2025.
XORTX Therapeutics (XRTX) Exchange Rate Effect (2021 - 2026) Analysis & Trends
XORTX Therapeutics' Exchange Rate Effect history runs 6 years deep, the most recent figure standing at -$763.0 for Q1 2026.
- Quarterly Exchange Rate Effect fell 167.7% year-over-year to -$763.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25107.0 (up 198.42% YoY) and the FY2025 annual result came in at $26997.0, up 175.09% from the prior year.
- Exchange Rate Effect was -$763.0 for Q1 2026 at XORTX Therapeutics, down from $4181.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $477968.9 in Q3 2022 and bottomed at -$133194.8 in Q1 2022.
- A 5-year average of $38990.6 and a median of $1127.0 in 2025 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect surged 9799.08% — and 2024, when it tumbled 2906.95%.
- XORTX Therapeutics' Exchange Rate Effect stood at $51141.9 in 2022, then plunged by 102.84% to -$1453.0 in 2023, then tumbled by 2906.95% to -$43691.0 in 2024, then soared by 109.57% to $4181.0 in 2025, then tumbled by 118.25% to -$763.0 in 2026.
- Business Quant data shows XRTX's Exchange Rate Effect at -$763.0 in Q1 2026, $4181.0 in Q4 2025, and -$5338.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | XORTX Therapeutics | 2.91 Bn | 2.91 Bn | - | -763.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -763.00 |
| Mar 31, 2026 | -763.00 |
| Dec 31, 2025 | 4,181.00 |
| Dec 31, 2025 | 4,181.00 |
| Sep 30, 2025 | -5,338.00 |
| Sep 30, 2025 | -5,338.00 |
| Jun 30, 2025 | 27,027.00 |
| Jun 30, 2025 | 27,027.00 |
| Mar 31, 2025 | 1,127.00 |
| Mar 31, 2025 | 1,127.00 |
| Dec 31, 2024 | -43,691.00 |
| Dec 31, 2024 | -43,691.00 |
| Sep 30, 2024 | 19,545.00 |
| Sep 30, 2024 | 19,545.00 |
| Jun 30, 2024 | -2,490.00 |
| Jun 30, 2024 | -2,490.00 |
| Mar 31, 2024 | -9,317.00 |
| Mar 31, 2024 | -9,317.00 |
| Dec 31, 2023 | -1,453.00 |
| Dec 31, 2023 | -1,453.00 |